Your browser doesn't support javascript.
loading
Enaminone amides as novel orally active GABAA receptor modulators.
Hogenkamp, Derk J; Johnstone, Timothy B C; Huang, Jin-Cheng; Li, Wen-Yen; Tran, Minhtam; Whittemore, Edward R; Bagnera, Rudy E; Gee, Kelvin W.
Afiliação
  • Hogenkamp DJ; Department of Pharmacology, School of Medicine, Med Surge 2, University of California-Irvine, Irvine, California 92697, USA. dhogenka@uci.edu
J Med Chem ; 50(14): 3369-79, 2007 Jul 12.
Article em En | MEDLINE | ID: mdl-17571865
ABSTRACT
A series of enaminone esters and amides have been developed as potent allosteric modulators of gamma-aminobutyric acidA (GABAA) receptors. The compounds bind to a novel modulatory site that is independent of the benzodiazepine (BZ), isosteric GABA, and neuroactive steroid binding sites. Structure-activity relationship (SAR) studies resulted in the synthesis of the c-Bu amide 16h with an in vitro potency of 7 nM based on inhibition of [35S]TBPS binding. The activity of the enaminones as positive allosteric modulators was confirmed with electrophysiological measurements in oocytes expressing alpha1beta2gamma2L GABAA receptors. The i-Pr, s-Bu, c-Pr, and c-Bu amides (16e-h) were orally active in mice with profound central nervous system depressant effects. The i-Pr amide 16e was an orally active anxiolytic in the mouse light-dark paradigm.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Receptores de GABA-A / Amidas Limite: Animals Idioma: En Ano de publicação: 2007 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Receptores de GABA-A / Amidas Limite: Animals Idioma: En Ano de publicação: 2007 Tipo de documento: Article